Literature DB >> 19902268

Resolution of chyloperitoneum in a preterm with octreotide, diet and cessation of dialysis.

Alper Soylu1, Demet Alaygut, Didem Yeşilirmak, Belde Kasap, Mehmet Türkmen, Nuray Duman, Salih Kavukçu.   

Abstract

The diagnosis of chyloperitoneum (CP) is based on the presence of high levels of triglycerides (TGs) in the dialysate. It is a rare complication of peritoneal dialysis (PD) and even rarer in neonates. We report here the case of CP in a 1700-g male baby delivered at the 30th gestational week due to posterior urethral valve and associated oligohydramnios. On postnatal day 2, the serum creatinine (Scr) was 1.6 mg/dL, and he was anuric. PD was instituted via a Tenckhoff catheter. At the end of the second week, after the initiation of enteral feeding, the ultrafiltrate became cloudy, with a leukocyte count of 900/mm(3). A treatment regimen consisting of intraperitoneal vancomycin and ceftazidime was then started. Five days later, the fluid became milky, with a TG level of 251 mg/dL. The patient was then placed on a diet based on medium-chain triglycerides and octreotide (1 microg/kg/h; increasing up to 2 microg/kg/h over 15 days). Although the TG and leukocyte levels decreased, the milky appearance persisted. PD was stopped for 2 days when the Scr decreased to 1.7 mg/dL. When it was resumed, the fluid was totally clear, with a TG level of 7 mg/dL. The infant was discharged with a nightly intermittent peritoneal dialysis program and has had no recurrence. In summary, we report a preterm infant who developed CP during PD and recovered following treatment that included diet modification, octreotide, and temporary discontinuation of the PD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19902268     DOI: 10.1007/s00467-009-1340-5

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  12 in total

1.  Consensus guidelines for the treatment of peritonitis in pediatric patients receiving peritoneal dialysis.

Authors:  B A Warady; F Schaefer; M Holloway; S Alexander; M Kandert; B Piraino; I Salusky; A Tranaeus; J Divino; M Honda; S Mujais; E Verrina
Journal:  Perit Dial Int       Date:  2000 Nov-Dec       Impact factor: 1.756

2.  Chylous ascites complicating neonatal peritoneal dialysis.

Authors:  J Z Melnick; C M McCarty; M P Hunchik; S R Alexander
Journal:  Pediatr Nephrol       Date:  1995-12       Impact factor: 3.714

3.  Chylous ascites: an unexpected complication that resembles peritonitis.

Authors:  H Currier
Journal:  ANNA J       Date:  1995-04

4.  Postoperative chylous ascites in a neonate treated successfully with octreotide: bile sludge and cholestasis.

Authors:  Alexander Andreou; Maria Papouli; Vaso Papavasiliou; Maria Badouraki
Journal:  Am J Perinatol       Date:  2005-11       Impact factor: 1.862

5.  Chyloperitoneum in a peritoneal dialysis patient.

Authors:  R I Levy; R E Wenk
Journal:  Am J Kidney Dis       Date:  2001-09       Impact factor: 8.860

6.  Octreotide therapy for chylous ascites in a chronic dialysis patient.

Authors:  Pei-Hsien Lee; Chun-Liang Lin; Ping-Chin Lai; Chih-Wei Yang
Journal:  Nephrology (Carlton)       Date:  2005-08       Impact factor: 2.506

7.  The management of chylous ascites in children.

Authors:  D W Man; L Spitz
Journal:  J Pediatr Surg       Date:  1985-02       Impact factor: 2.545

Review 8.  Chylous ascites: an unusual complication of peritoneal dialysis. A case report and literature review.

Authors:  Chee Kay Cheung; Arif Khwaja
Journal:  Perit Dial Int       Date:  2008 May-Jun       Impact factor: 1.756

9.  Chylous ascites in a patient treated with intermittent peritoneal dialysis.

Authors:  H M Humayun; J T Daugirdas; T S Ing; D J Leehey; V C Gandhi; S Popli
Journal:  Artif Organs       Date:  1984-08       Impact factor: 3.094

Review 10.  Chylous ascites in infants and children.

Authors:  S W Unger; J G Chandler
Journal:  Surgery       Date:  1983-03       Impact factor: 3.982

View more
  2 in total

1.  Milky appearance of peritoneal fluid in a neonate on peritoneal dialysis due to end-stage renal disease: Answers.

Authors:  Xiaoyan Wu; Molly Vega; Sarah J Swartz; Mini Michael
Journal:  Pediatr Nephrol       Date:  2017-03-10       Impact factor: 3.714

2.  Safety of octreotide in hospitalized infants.

Authors:  Daniela Testoni; Christoph P Hornik; Megan L Neely; Qinghong Yang; Ann W McMahon; Reese H Clark; P Brian Smith
Journal:  Early Hum Dev       Date:  2015-05-15       Impact factor: 2.699

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.